Delivery Order SPE2DB22D3301-SPE2DB24FX6JP
Award Date 12/4/23
Potential Completion Date 12/5/23
Potential Value $1.8K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This federal contract award, valued at $1,530.70, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-Amlodipine 40-10 30S, a medication, with a completion date of June 10, 2025. The contract is a Firm Fixed Price Delivery Order and is not set aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA...
- This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $1,362.24, is a Delivery Order contract for Telmisartan-Amlodipine 40-5 mg tablets. The contract is for a fixed price and has an ultimate completion date of April 7, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-Amlodipine 40-5 mg tablets. The $2,774.37 Firm Fixed Price delivery order contract has an ultimate completion date of September 11, 2024. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as the primary...
- This contract award is from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,998.58 firm fixed price delivery order is for the pharmaceutical product Telmisartan-Amlodipine 40-5 mg, with a completion date of June 29, 2023. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical that serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The $3,356.61 delivery order covers the supply of Telmisartan-HCTZ 80-12.5 mg tablets to support military healthcare programs. The contract has a period of performance through May 11, 2023 and utilizes a firm fixed price pricing structure. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc. The contract, valued at $2,475.23, is a delivery order for the pharmaceutical product Telmisartan-Amlodipine 40-10 30S. The award has an ultimate completion date of December 7, 2023 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical...
- This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,793.28, is for the supply of Telmisartan-Amlodipine 40-5 mg tablets. The contract has an ultimate completion date of March 4, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,486.25 firm fixed-price delivery order covers the supply of Telmisartan-Amlodipine 40-10 30S, a cardiovascular medication, with a period of performance through November 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical to provide a comprehensive...
- This contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $1,936.38 for the supply of Telmisartan-Amlodipine 40-5 mg medication. The contract is awarded by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of January 21, 2025. The contract type is Firm Fixed Price. This award is part of a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical,...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $1,296.81, is for the delivery of Telmisartan-Amlodipine 80-10 medication in 30-count supplies. The contract has a completion date of September 11, 2023 and is structured as a firm fixed-price delivery order. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc., which is also registered in the System...